Loading
Latest filing published 27 May 2014 for Plandai Biotechnology, Inc., €6,849.
No signal scores available.
David Rzepnicki appears in our data through filings on Plandai Biotechnology, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 8 March 2012 and the latest from 1 January 2014.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 27 May 2014 with a share grant (€6,849) in Plandai Biotechnology, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations